Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Peer Christiansen"'
Autor:
Christian Godballe, Kristine Zøylner Swan, Viveque Egsgaard Nielsen, Peer Christiansen, Henrik Baymler Pedersen, Marie Riis Mortensen, Jens Faunø Thrane, Steen Joop Bonnema, Sten Schytte
Publikováno v:
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308–316 . https://doi.org/10.1007/s12020-018-1637-x
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308-316 . https://doi.org/10.1007/s12020-018-1637-x
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308-316 . https://doi.org/10.1007/s12020-018-1637-x
PURPOSE: To investigate the association between the pre-operative serum TSH (s-TSH) level and differentiated thyroid carcinoma (DTC) in a mildly iodine-deficient area.METHODS: Patients undergoing surgery for thyroid nodular disease (TND) were include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab10549ce73b23d0860ac433d6b5deb
https://vbn.aau.dk/da/publications/a7e1d251-6f89-4960-8450-5e12dfe20acb
https://vbn.aau.dk/da/publications/a7e1d251-6f89-4960-8450-5e12dfe20acb
Autor:
Peer Christiansen, Lars Rolighed, Leif Mosekilde, Tanja Sikjaer, Peter Vestergaard, Lene Heickendorff, Lars Rejnmark
Publikováno v:
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-617 . https://doi.org/10.1530/EJE-14-0940
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', Bone Abstracts, vol. 3, PP210 . https://doi.org/10.1530/boneabs.3.PP210
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-17 . https://doi.org/10.1530/EJE-14-0940
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', Bone Abstracts, vol. 3, PP210 . https://doi.org/10.1530/boneabs.3.PP210
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-17 . https://doi.org/10.1530/EJE-14-0940
ContextImpairments of muscle function and strength in patients with primary hyperparathyroidism (PHPT) are rarely addressed, although decreased muscle function may contribute to increased fracture risk.ObjectiveWe aimed to assess the changes in muscl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb67bdca42b3bacd816cb3f1020352b
https://vbn.aau.dk/da/publications/ba201401-ed6b-4c5f-8eac-4ea23a3958f7
https://vbn.aau.dk/da/publications/ba201401-ed6b-4c5f-8eac-4ea23a3958f7
Autor:
P. Vestergaard, F. Melsen, Lene Heickendorff, Bjarke Moosgaard, Lis Mosekilde, Peer Christiansen
Publikováno v:
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, no. 63, pp. 506-513 .
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, vol. 63, no. 5, pp. 506-513 . https://doi.org/10.1111/j.1365-2265.2005.02371.x
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, vol. 63, no. 5, pp. 506-513 . https://doi.org/10.1111/j.1365-2265.2005.02371.x
Background: Primary hyperparathyroidism (PHPT) and vitamin D insufficiency are common conditions that can occur in combination. However, low plasma 25-hydroxyvitamin D (25OHD) may also enhance the risk of PHPT or modify disease severity. Aim: To comp
Autor:
Lone Bording Astrup, Peer Christiansen, Ludwig Wagner, Bernhard Heine, Hans Scherübl, Torben F. Ørntoft, Flemming Brandt Sørensen, Wolfgang Gärtner, Karin Birkenkamp-Demtröder
Publikováno v:
Aarhus University
Birkenkamp-Demtröder, K, Wagner, L, Brandt Sørensen, F, Bording Astrup, L, Gartner, W, Scherübl, H, Heine, B, Christiansen, P & Ørntoft, T F 2005, ' Secretagogin is a novel marker for neuroendocrine differentiation ', Neuroendocrinology, vol. 82, no. 2, pp. 121-38 . https://doi.org/10.1159/000091207
Birkenkamp-Demtröder, K, Wagner, L, Astrup, L B, Sørensen, F B, Gartner, W, Scherubl, H, Heine, B, Christiansen, P M C & Ørntoft, T F 2005, ' Secretagogin is a novel marker for neuroendocrine differentiation ', Neuroendocrinology, vol. 82, no. 2, pp. 121-138 .
Birkenkamp-Demtröder, K, Wagner, L, Brandt Sørensen, F, Bording Astrup, L, Gartner, W, Scherübl, H, Heine, B, Christiansen, P & Ørntoft, T F 2005, ' Secretagogin is a novel marker for neuroendocrine differentiation ', Neuroendocrinology, vol. 82, no. 2, pp. 121-38 . https://doi.org/10.1159/000091207
Birkenkamp-Demtröder, K, Wagner, L, Astrup, L B, Sørensen, F B, Gartner, W, Scherubl, H, Heine, B, Christiansen, P M C & Ørntoft, T F 2005, ' Secretagogin is a novel marker for neuroendocrine differentiation ', Neuroendocrinology, vol. 82, no. 2, pp. 121-138 .
Our previous microarray-based studies identified secretagogin to be highly expressed in normal colon mucosa compared to basal expression in colon adenocarcinomas. The aim of this study was to analyze the differential expression of secretagogin in nor
Autor:
Lars Rolighed, Peer Christiansen, Tanja Sikjaer, Lars Rejnmark, Lene Heickendorff, Leif Mosekilde, Peter Vestergaard
Publikováno v:
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 3, jc20133978, pp. 1072-1080 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : a Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20133978 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjær, T T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P M 2013, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Bone and Mineral Research, vol. 28, no. Suppl. 1, SU0182 .
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : a Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20133978 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjær, T T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P M 2013, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Bone and Mineral Research, vol. 28, no. Suppl. 1, SU0182 .
Low 25-hydroxyvitamin D levels are common in patients with primary hyperparathyroidism (PHPT) and associated with higher PTH levels and hungry bone syndrome after parathyroidectomy (PTX). However, concerns have been raised about the safety of vitamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bac43c66e28bf00be48c14c968540d9
https://vbn.aau.dk/da/publications/ab4b6166-881a-4277-afb2-d70ddaf16c06
https://vbn.aau.dk/da/publications/ab4b6166-881a-4277-afb2-d70ddaf16c06
Autor:
Lars Bastholt, Christian Godballe, Waldemar Trolle, Peer Christiansen, Sten Schytte, Jens Bentzen, Henrik Baymler Pedersen, Stefano Christian Londero, Jens Overgaard, Annelise Krogdahl
Publikováno v:
Londero, S C, Krogdahl, A, Bastholt, L, Overgaard, J, Trolle, W, Pedersen, H B, Bentzen, J, Schytte, S, Christiansen, P, Godballe, C & Danish Thyroid Cancer Group 2013, ' Papillary thyroid microcarcinoma in Denmark 1996-2008 : a national study of epidemiology and clinical significance ', Thyroid, vol. 23, no. 9, pp. 1159-64 . https://doi.org/10.1089/thy.2012.0595
Londero, S C, Krogdahl, A, Bastholt, L, Overgaard, J, Trolle, W, Pedersen, H B, Bentzen, J D, Schytte, S, Christiansen, P M, Godballe, C & Danish Thyroid Cancer Group 2013, ' Papillary thyroid microcarcinoma in Denmark 1996-2008 : a national study of epidemiology and clinical significance ', Thyroid, vol. 23, no. 9, pp. 1159-64 . https://doi.org/10.1089/thy.2012.0595
Londero, S C, Krogdahl, A, Bastholt, L, Overgaard, J, Trolle, W, Pedersen, H B, Schytte, S, Bentzen, J, Christiansen, P M & Godballe, C 2013, ' Papillary thyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance ', Thyroid, vol. 23, no. 9, pp. 1159-64 . https://doi.org/10.1089/thy.2012.0595
Londero, S C, Krogdahl, A, Bastholt, L, Overgaard, J, Trolle, W, Pedersen, H B, Bentzen, J D, Schytte, S, Christiansen, P M, Godballe, C & Danish Thyroid Cancer Group 2013, ' Papillary thyroid microcarcinoma in Denmark 1996-2008 : a national study of epidemiology and clinical significance ', Thyroid, vol. 23, no. 9, pp. 1159-64 . https://doi.org/10.1089/thy.2012.0595
Londero, S C, Krogdahl, A, Bastholt, L, Overgaard, J, Trolle, W, Pedersen, H B, Schytte, S, Bentzen, J, Christiansen, P M & Godballe, C 2013, ' Papillary thyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance ', Thyroid, vol. 23, no. 9, pp. 1159-64 . https://doi.org/10.1089/thy.2012.0595
BACKGROUND: With an observed general rise in papillary thyroid carcinoma incidence, papillary microcarcinoma (PMC) is accordingly found more frequently and often incidentally by histological examination of surgical specimens from presumed benign thyr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbe7936a4acb0fc863682c49d4c750a
https://vbn.aau.dk/da/publications/158ce528-9005-4faa-aad6-e6921b5e271f
https://vbn.aau.dk/da/publications/158ce528-9005-4faa-aad6-e6921b5e271f
Autor:
F. Melsen, Le. Mosekilde, R. Ullerup, Ib Hessov, Peer Christiansen, Torben Steiniche, A. Vesterby
Publikováno v:
Bone. 26:535-543
In 19 patients with primary hyperparathyroidism (PHPT) (14 women and 5 men; age 53 +/- 11 years, range 29-69 years), bone densitometry, biochemical markers of bone turnover, and iliac crest bone biopsies were obtained before and 3 years after success
Autor:
Peer Christiansen, Leif Mosekilde, Peter Vestergaard, Tanja Sikjaer, Lene Heickendorff, Lars Rejnmark, Lars Rolighed
Publikováno v:
Rolighed, L, Vestergaard, P, Heickendorff, L, Sikjaer, T, Rejnmark, L, Mosekilde, L & Christiansen, P 2013, ' BMD improvements after operation for primary hyperparathyroidism ', Langenbecks Archives of Surgery, vol. 398, no. 1, pp. 113-20 . https://doi.org/10.1007/s00423-012-1026-5
PURPOSE: This study aims to quantify bone mineral density (BMD) changes following surgery in patients with primary hyperparathyroidism (PHPT) and to assess their relationship with clinical and biochemical variables. METHODS: A historic cohort of 236
Publikováno v:
Vestergaard, P, Fischer, L, Mele, M, Mosekilde, L & Christiansen, P 2011, ' Use of bisphosphonates and risk of breast cancer ', Calcified Tissue International, vol. 88, no. 4, pp. 255-62 . https://doi.org/10.1007/s00223-011-9463-7
A decreased risk of breast cancer has been reported among patients given bisphosphonates. The present aims were to study potential associations between different antiosteoporosis drugs, including bisphosphonates, and the risk of breast cancer before
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::304ccc4ce2d26fa1260870fd59238388
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html
https://pure.au.dk/portal/da/publications/use-of-bisphosphonates-and-risk-of-breast-cancer(68122498-da7d-4afa-8132-00de60340b8f).html
Autor:
Bjarke Moosgaard, Peer Christiansen, P. Vestergaard, Signe Engkjaer Christensen, Lis Mosekilde, Lene Heickendorff
Publikováno v:
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2007, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, no. 5, pp. 707-15 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2008, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, pp. 707-715 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Moosgaard, B, Christensen, S E, Vestergaard, P, Heickendorff, L, Christiansen, P M & Mosekilde, L 2008, ' Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism ', Clinical Endocrinology, vol. 68, pp. 707-715 . https://doi.org/10.1111/j.1365-2265.2007.03109.x
Udgivelsesdato: 2008-May BACKGROUND: Primary hyperparathyroidism (PHPT) is associated with reduced bone mineral density (BMD) mainly at sites rich in cortical bone. However, successful parathyroidectomy causes an increase in BMD especially at sites r